[at noodls] – WEST LAFAYETTE, Ind., April 3, 2013 (GLOBE NEWSWIRE) — Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics … moreView todays social media effects on ECYTView the latest stocks trending across Twitter. Click to view dashboardSee who Endocyte is hiring next, click here to view […]
[at noodls] – WEST LAFAYETTE, Ind., March 18, 2013 (GLOBE NEWSWIRE) — Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics … moreView todays social media effects on ECYTView the latest stocks trending across Twitter. Click to view dashboardSee who Endocyte is hiring next, click here to view […]
[at noodls] – Patients With 100 Percent Folate Receptor-Positive Tumor Lesions Experienced Substantial Progression-Free Survival When Treated With Vintafolide New Data Presented at AACR-SNMMI Joint Conference on State-of-the-Art … moreView todays social media effects on ECYTView the latest stocks trending across Twitter. Click to view dashboardSee who Endocyte is hiring next, click here to view […]
[at noodls] – WEST LAFAYETTE, Ind., Feb. 7, 2013 (GLOBE NEWSWIRE) — Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics … moreView todays social media effects on ECYTView the latest stocks trending across Twitter. Click to view dashboardSee who Endocyte is hiring next, click here to view […]
[at noodls] – Company Expects to File IND for Therapeutic Agent in 2013 Human Study of Companion Imaging Agent EC0652 Demonstrates Safety and Binding Specificity WEST LAFAYETTE, Ind., Jan. 29, 2013 (GLOBE NEWSWIRE) … moreView todays social media effects on ECYTView the latest stocks trending across Twitter. Click to view dashboardSee who Endocyte is hiring next, click here to view […]
[at noodls] – WEST LAFAYETTE, Ind., Jan. 8, 2013 (GLOBE NEWSWIRE) — Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics … moreView todays social media effects on ECYTView the latest stocks trending across Twitter. Click to view dashboardSee who Endocyte is hiring next, click here to view […]
[ACN Newswire] – By David Sobek Endocyte (NASDAQ:ECYT) recently confirmed that the Marketing Authorization Application (MAA) filing process for vintafolide and etarfolatide in Europe is set to be completed by the end of … moreView todays social media effects on ECYTView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – WEST LAFAYETTE, Ind., Nov. 6, 2012 (GLOBE NEWSWIRE) — Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics … moreView todays social media effects on ECYTView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – -MAA Filing Process for Vintafolide and Etarfolatide on Schedule for Completion by Year-End 2012 – -Conference call today at 4:30 EDT – WEST LAFAYETTE, Ind., Nov. 1, 2012 (GLOBE NEWSWIRE) — Endocyte, … moreView todays social media effects on ECYTView the latest stocks trending across Twitter. Click to view dashboard […]
